depression and 50 healthy controls. Serum lipids levels were determined using standard laboratory tests. All patients had significantly lower HDL-C values than control subjects.
Introduction
Various studies (Horsten et al., 1997; Maes et al., 1997; Ghaemi et al., 2000; Atmaca et al., 2002; Cassidi and Carroll, 2002; Pae et al., 2004) suggested that pathophysiology of mood disorders might be related to the alterations in the lipid profile. Although in general population women with low levels of high-density lipoprotein cholesterol (HDL-C) (Horsten et al., 1997; Chen et al., 2001 ) and low cholesterol levels (Horsten et al., 1997) had more depressive symptoms than women with normal lipid levels, the association between total cholesterol, HDL-C, low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) levels and affective disorders is still not clear. Namely, clinical studies evaluating the relationship between cholesterol levels and affective disorders yielded inconsistent results. Decreased cholesterol levels were found in patients with mania (Ghaemi et al., 2000; Cassidi and Carroll, 3. Results The demographic characteristics of patients and healthy controls are presented in Table 1 . No significant difference in age (F 3, 121 =2.011, P=0.11, ANOVA) and BMI (F 3, 121 =1.581, P=0.19) was observed between groups.
Serum HDL-C levels were significantly (F 3, 121 =22.575, P=0.000) different in healthy controls and patients with major depressive or bipolar disorder (Fig. 1) . Significantly lower serum HDL-C values were observed in patients with bipolar disorder in manic (P<0.001; Tukey's HSD) or depressive (P<0.001, Tukey's test) episodes, and with major depression (P<0.001, Tukey's test), when compared to healthy controls. HDL-C levels were significantly different among groups when data were adjusted for age (F 4 =18.606, P<0.000), smoking (F 4 = 16.838, P<0.000) and menopause (F 4 = 18.968, P<0.000) as covariates (ANCOVA).
There was a significant (F 3 =6.909, P<0.000) difference in serum TG levels among groups (Fig. 2) . Patients with bipolar disorders in manic (P=0.007, Tukey's HDS test) or depressive (P<0.001 Tukey's HDS test) episode had significantly higher TG values than healthy controls. Serum TG values were significantly (P<0.048) higher in bipolar disorder in a depressed phase, than in patients with major depression. TG levels were significantly different among groups when data were adjusted for age (F 4 = 5,195, P<0.001) Atherogenic index differed significantly among groups (Table 2 ). Patients with major depression and patients with both phases of bipolar disorder had significantly (P<0.000, Tukey's HSD) higher cholesterol/HDL-C and LDL-C/HDL-C ratios than healthy controls.
Patients with bipolar disorder in a depressive phase (Table 2) had significantly (P=0.045, Tukey's HSD) higher cholesterol/HDL-C ratio than bipolar patients in a manic phase and patients with major depression (P<0.012, Tukey's HSD). The LDL-C/HDL-C ratio was significantly (P=0.01, Tukey's HSD) higher in patients with bipolar disorder in a depressive phase than in patients with major depression (Table 2 ).
Discussion
The results of the present study showed that patients with major depression and bipolar disorder (in a manic and a depressed episode) had lower HDL-C values and higher atherogenic index (cholesterol/HDL-C and LDL-C/HDL-C) than control subjects. In addition, we have shown the higher TG levels in patients with bipolar disorder, both in a manic and a depressed phase compared to patients with major depression or healthy controls.
Our data agree with the reported association between low HDL-C levels and depression (Maes et al., 1997; Huang, 2005) . Low HDL-C levels were proposed to be a characteristic feature of major depression per se, and not of the subgroups such as melancholia (Maes et al., 1997 , Huang, 2005 , treatment resistant depression (Maes et al., 1997), or single or recurrent episodes (Huang, 2005) . Our results suggest that lower HDL-C levels and higher atherogenic index, found in patients with major depression, patients with bipolar depression, and patients with mania, might represent a hallmark of affective disorders. These results also agree with the hypothesis that HDL-C might be a trait, rather than a state marker in bipolar disorders (Sobczak et al., 2004) .
Lower HDL-C values might be influenced by different factors such as sex, cholesterollowering drugs, suicidal behavior, or altered serotonergic function. Sex differences in lipid levels, with lower HDL-C levels (Sudhop, 1999; Zhang et al., 2005) and higher LDL and TG levels (Sudhop, 1999) in healthy men than in healthy women were found. Since present study included only female subjects, lower HDL-C levels were not influenced by sex. Recent suicidal attempts were shown to decrease HDL-C levels in depressed men but not in depressed women (Maes et al., 1997) . In our study patients with recent suicidal attempt were not included, and therefore lower HDL-C levels were not due to the history of suicidal behavior. Lower HDL-C levels might result from the altered serotonergic function (BuydensBranchey et al., 2000) , as indicated by the positive correlations between HDL-C levels and serotonin metabolite, 5-hydroxyindoleacetic acid, in suicide attempters (Engstrom et al., 1995) , altered platelet serotonin in bipolar disorder (Sagud et al., 2007) , and the inverse relationship between platelet serotonin and suicidal behavior in depressed patients (MuckSeler et al., 1996) . , 2007) . Since our study included medication-free female subjects who were not suicidal, and their BMI did not differ between groups, our results agree with the suggestion that cholesterol levels could not be biological marker for major depression (Oxenkrug et al., 1983) . In addition, our results obtained in medication free patients suggest that both cholesterol and LDL-C levels are not related to diagnostic entities such as major depression or bipolar disorder. The differences in the lipid profile among studies might be related to the diverse medication status. Namely, it has been reported that treatment with antidepressants (Maes et al., 1997) , and psychoactive drugs (Glueck et al., 1994) , significantly decreased both serum cholesterol and HDL-C levels in patients with major depression, or affective disorders. Numerous psychoactive drugs were shown to influence lipid levels: valproate reduced cholesterol levels (Bowden and Singh, 2005) , carbamazepine increased cholesterol, LDL-C and HDL-C levels (Weisler et al., 2005) , while antipsychotic drugs increased cholesterol, TG and LDL-C levels (Saari et al., 2004) . Therefore, the comparison of cholesterol levels in patients receiving pharmacological treatment and medication-free healthy controls (Glueck et al., 1994 ) is questionable.
HDL-C has a role in the reverse cholesterol transport and complex cholesterol homeostasis, processes important in the protection of the cardiovascular system (Norata et al., 2006; Sampietro et al., 2006) . The results of our study, showing low HDL-C and high TG levels, suggest that patients with mood disorders are at higher risk for the development of cardiovascular disorders (Lesperance et al., 1996; Polk and Naqui, 2005 ). Since we have also found that mean HDL-C values in our female patients with mania, bipolar and major depression were within the values associated with the greatest risk for development of coronary heart disease (Wilson et al., 1998; Franceschini, 2001 ), these results recommend that our patients should be further followed up.
The limitations of the study were that the data on the physical activity, alcohol and dietary habits were not collected. In addition, we did not measure HDL-C subclasses (Yang et al 2005) .
In conclusion, our data showed an inverse relationship between HDL-C and TG levels in patients with mood disorders, particularly in those with bipolar disorder (in a manic or a depressive phase). Due to the cross-sectional design, it is not possible to conclude whether low HDL-C levels and high atherogenic index contributed to a vulnerability to develop affective disorders, or low HDL-C levels occurred during the course of mood disorders. Since low HDL-C and increased atherogenic index are the risk factors for development of coronary heart disease, further investigations of lipid metabolism in affective disorders are warranted. Disorder duration (years) 9.4 ± 9.6 12.5 ± 9.8 12.7 ± 10.4
Current episode duration (days) 10.4 ± 11.3 4.2 ± 3.0 3.2 ± 1.5
Number of prior manic episodes 5.2 ± 7.5 4.6 ± 5.8
Number of prior depressive episodes 6.7 ± 9.2 7.9 ± 7.8 3.1 ± 2.9 Table 2 . Serum cholesterol, LDL-C levels and atherogenic index (cholesterol/HDL-C and LDL-C/HDL-C ratio) in healthy controls, patients with major depressive disorders, and patients with bipolar disorders in manic or depressive episodes. Results are expressed as means  SD. Number of subjects is given in brackets. 
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